1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Key Pharma News 02 FEBRUARY 2015

Key Pharma News 02 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 32 pages

Industry Trend Analysis - Approval Of Evotaz Will Keep BMS In HIV Market But Gilead Will Prevail Once Again
Industry Trend Analysis - Several Stakeholders To Benefit From Gilead's Expanded Deals With Indian Generics Companies
Industry Brief - BI/Sanofi Team Up To Produce Biopharmaceuticals
Industry Trend Analysis - Genomic Data Partnerships Will Bolster Drug Development
Industry Trend Analysis - J&J's Investment Will Secure Oncology Segment's Growth
Industry Trend Analysis - Nucynta Deal Will More Than Double Depomed's Annual Net Product Sales
Industry Brief - Merck Completes Tender Offer To Acquire Cubist
Industry Brief - Otsuka Opens Office In Australia
Industry Brief - Roche To Acquire Trophos
Industry Brief - Regado/Tobira Merger To Create NASH Focused Company
Industry Trend Analysis - Actavis' First Acquisition Of 2015 Will Boost Its UK Generics Presence
Industry Trend Analysis - J&J's Three-Month Antipsychotic Will Be A Growth Driver
Industry Brief - AbbVie's Viekirax/Exviera Licensed For Use In UK For cHCV
Industry Trend Analysis - Amgen's Filings For Kyprolis In MM Will Not Affect Celgene's Product Sales
Industry Trend Analysis - Novartis Vaccine Business Picks Up Owing To Expanding Meningitis Market; Well-Timed For GSK
Industry Brief - GSK Extends Price Freeze Commitment For Gavi-Eligible Countries
Industry Trend Analysis - EU Approval Sets Stage For Otezla's Blockbuster Future
Industry Brief - UCB's Brivaracetam Applications Accepted For Review By FDA/EMA
Industry Brief - GSK Launches Two Products In US For Asthma/COPD
Industry Brief - Novo Nordisk Launches Xultophy In Switzerland
Industry Trend Analysis - EU Approval For Ofev In IPF Will Create A Blockbuster In An Intense Market
Industry Brief - FDA Approves Symplmed's Prestalia For Hypertension
Industry Trend Analysis - Novartis In Pole Position With Cosentyx' EU Approval For Plaque Psoriasis
Industry Brief - EC Grants Marketing Authorisation For Genzyme's Cerdelga
Industry Brief - EMA Accepts Samsung Bioepis' Etanercept Biosimilar For Review
Industry Trend Analysis - Supreme Court Ruling Will Boost Teva's Copaxone Revenues
Industry Brief - Milestone Triggered As Novartis' Jakavi Gains CHMP Positive Opinion For Polycythaemia Vera
Industry Brief - Novartis' Cosentyx Gains FDA Approval For Plaque Psoriasis
Industry Trend Analysis - Europe Opening Up To Adult ADHD
Industry Brief - CHMP Adopts Positive Opinion On Saxenda For Obesity
Industry Brief - Purdue's Abuse-Deterrent Hysingla ER Available In US
Industry Brief - CHMP Adopts Positive Opinion On Abraxane For First-Line NSCLC
Industry Brief - FDA Accepts Praluent BLA For Priority Review
Industry Brief - CHMP Issues Positive Opinions For Kengrexal/Orbactiv/Raplixa
Industry Trend Analysis - AstraZeneca Will Look To Other Regions As US Generic Nexium Competition Commences
Industry Trend Analysis - Pfizer Heads Straight For Most Competitive Indication In Immuno-Oncology Market
Industry Brief - Richter/Actavis Report Positive Phase III Results For Cariprazine
Industry Trend Analysis - Waning Of Ebola Outbreak Could Hamper Vaccine Developments
Industry Trend Analysis - CAR-T Market Gaining Traction

Table Of Contents

Key Pharma News 02 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.